Pricing Log in Create free account

Atara Biotherapeutics, Inc. (ATRA) vs Novogen Limited (KZIA)

Atara Biotherapeutics, Inc. and Novogen Limited are both Biotechnology companies. Atara Biotherapeutics, Inc. and Novogen Limited are of similar size ($80.0M and $79.9M). Novogen Limited has the higher net margin (0.00% vs −269.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Novogen Limited leads on 6 and Atara Biotherapeutics, Inc. on 5.

Valuation

Metric ATRA KZIA Biotechnology median
P/E n/m n/m 10.60
P/S 19.27 — 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 1.46 0.66
EV/Sales 17.68 n/m 9.02
Earnings yield (14.86%) (2.99%) (32.88%)
Free cash flow yield (17.62%) 0.00% (23.13%)

Profitability

Metric ATRA KZIA Biotechnology median
Gross margin 91.38% 0.00% 68.51%
Operating margin (229.67%) — 0.00%
Net margin (269.42%) 0.00% 0.00%
Free cash flow margin (353.49%) 0.00% 0.00%
Return on equity 46.33% 0.00% (51.96%)
Return on assets (57.62%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATRA KZIA Biotechnology median
Revenue growth (TTM) (96.72%) — 6.76%
EPS growth (last fiscal year) 122.52% 63.24% 29.88%
Revenue growth, 5-year CAGR — 11.56% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATRA KZIA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.98 2.87 4.97
Net debt to EBITDA (0.22) 0.30 1.01

Dividend

Metric ATRA KZIA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATRA KZIA Biotechnology median
Market cap 79.90m 80.01m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack